Xinghao Pharmaceutical announced that its shareholder Beijing SL PHARM Co., Ltd., holding more than 5% of the shares, plans to reduce its holdings by no more than 1.85 million shares, accounting for 1.51% of the company's total share capital. The reduction will be conducted through centralized bidding or block trading, and the reduction period will be within three months after 30 trading days from the date of the announcement. The reduction price will be determined based on the secondary market price at the time of the reduction, and the reason for the reduction is funding needs
